Skip to content

Drug interactions

Isocarboxazid + Solriamfetol

Severity: Contraindicated

Isocarboxazid and Solriamfetol: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Solriamfetol raises dopamine and noradrenaline activity, and with an MAOI it can lead to hypertensive crisis. Labeling prohibits use during MAOI therapy and for 14 days after stopping it.

What this interaction means in plain words

Isocarboxazid and Solriamfetol are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Isocarboxazid belongs to Central Nervous System; Solriamfetol belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Dopamine and noradrenaline reuptake inhibition augmented by loss of MAO-mediated degradation.

What to do

Avoid during and for 14 days after MAOI use; consider another wake-promoting agent without adrenergic load.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Isocarboxazid and Solriamfetol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Isocarboxazid with Solriamfetol?

MediHelp rates the interaction as contraindicated. Isocarboxazid and Solriamfetol are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Solriamfetol raises dopamine and noradrenaline activity, and with an MAOI it can lead to hypertensive crisis. Labeling prohibits use during MAOI therapy and for 14 days after stopping it.

How serious is the interaction between Isocarboxazid and Solriamfetol?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid during and for 14 days after MAOI use; consider another wake-promoting agent without adrenergic load.

What other medicines interact with Isocarboxazid?

MediHelp also lists interactions of Isocarboxazid with, for example, 5-HTP, Amitriptyline, Amobarbital. The full list is on the Isocarboxazid page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in